Malignant pleural mesothelioma: Current concepts in treatment

Nature Clinical Practice Oncology

Volumn 4, Issue 6, 2007, Pages 344-352

  Tsiouris, Athanasios ^a   Walesby, Robin K ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; BEVACIZUMAB; CARBOPLATIN; CISPLATIN; CYTOTOXIC AGENT; DOXORUBICIN; GEMCITABINE; MITOMYCIN C; NARCOTIC ANALGESIC AGENT; PEMETREXED; RALTITREXED; RANPIRNASE; STEROID; TALC; VINBLASTINE;

ADJUVANT THERAPY; ANTINEOPLASTIC ACTIVITY; CANCER INCIDENCE; CANCER SURVIVAL; CHEMICAL CARCINOGENESIS; CLINICAL FEATURE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DRUG RESPONSE; EVIDENCE BASED MEDICINE; HEART ARRHYTHMIA; HISTOPATHOLOGY; HUMAN; INDUSTRIALIZATION; INTERMETHOD COMPARISON; LUNG RESECTION; MALIGNANT MESOTHELIOMA; META ANALYSIS; MONOTHERAPY; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; OCCUPATIONAL CANCER; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PLEURA MESOTHELIOMA; PLEURECTOMY; PLEURODESIS; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RADIATION RESPONSE; RADIOSENSITIVITY; RECOMMENDED DRUG DOSE; REVIEW; SURGICAL APPROACH; SYSTEMATIC REVIEW; THORACOSCOPY; THORAX RADIOGRAPHY; TREATMENT FAILURE;

ANIMALS; ANTINEOPLASTIC AGENTS; ASBESTOS; CISPLATIN; CLINICAL TRIALS; COMBINED MODALITY THERAPY; GLUTAMATES; GUANINE; HUMANS; MESOTHELIOMA; PLEURAL NEOPLASMS; RADIATION TOLERANCE; TREATMENT OUTCOME;

EID: 34249864432     PISSN: 17434254     EISSN: 17434262     Source Type: Journal    
DOI: 10.1038/ncponc0839     Document Type: Review

References (45)

1. Roggli VL et al. (2002) Malignant mesothelioma and occupational exposure to asbestos: A clinicopathological correlation of 1445 cases. Ultrastruct Pathol 26: 55-65
2. Sebastien P et al. (1980) Asbestos retention in human respiratory tissues: Comparative measurements in lung parenchyma and in parietal pleura. IARC Sci Publ 30: 237-246
3. Ault JG et al. (1995) Behavior of crocidolite asbestos during mitosis in living vertebrate lung epithelial cells. Cancer Res 55: 792-798
4. Weitzman SA and Graceffa P (1984) Asbestos catalyzes hydroxyl and superoxide radical generation from hydrogen peroxide. Arch Biochem Biophys 228: 373-376
5. Gazdar AF and Carbone M (2003) Molecular pathogenesis of malignant mesothelioma and its relationship to simian virus 40. Clin Lung Cancer 5: 177-181
6. Carbone M et al. (1997) Simian virus-40 large-T antigen binds p53 in human mesotheliomas. Nat Med 3: 908-912
7. Barbanti-Brodano G et al. (2004) Simian virus 40 infection in humans and association with human diseases: Results and hypotheses. Virology 318: 1-9
8. Shivapurkar N et al. (1999) Presence of simian virus 40 sequences in malignant mesotheliomas and mesothelial cell proliferations. J Cell Biochem 76: 181-188
9. López-Ríos F et al. (2004) Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids. Lancet. 364: 1157-1166
10. Gazdar AF and Carbone M (2003) Molecular pathogenesis of malignant mesothelioma and its relationship to simian virus 40. Clin Lung Cancer 5: 177-181
11. Zellos L and Sugarbaker DJ (2002) Current surgical management of malignant pleural mesothelioma. Curr Oncol Rep 4: 354-360
12. Tsiouris A et al. (2006) Current trends in the management of malignant pleural mesothelioma. Expert Rev Anticancer Ther 6: 831-833
13. Goerres GW et al. (2004) Why most PET of lung and head-and-neck cancer will be PET/CT. J Nucl Med 45 (Suppl 1): S66-S71
14. Butchart EG et al. (1976) Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura: Experience with 29 patients. Thorax 31: 15-24
15. Pass HI et al. (1997) Surgically debulked malignant pleural mesothelioma: Results and prognostic factors. Ann Surg Oncol 4: 215-222
16. Rusch VW et al. (1991) The role of extrapleural pneumonectomy in malignant pleural mesothelioma: A Lung Cancer Study Group trial. J Thorac Cardiovasc Surg 102: 1-9
17. Calavrezos A et al. (1988) Malignant mesothelioma of the pleura: A prospective therapeutic study of 132 patients from 1981-1985. Klin Wochenschr 66: 607-613
18. Rusch VW and Venkatraman ES (1999) Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. Ann Thorac Surg 68: 1799-1804
19. Allen KB et al. (1994) Malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy. Chest Surg Clin N Am 4: 113-126
20. Pass HI et al. (1998) Preoperative tumor volume is associated with outcome in malignant pleural mesothelioma. J Thorac Cardiovasc Surg 115: 310-317
21. Aziz T et al. (2002) The management of malignant pleural mesothelioma; single centre experience in 10 years. Eur J Cardiothorac Surg 22: 298-305
22. Sugarbaker DJ et al. (1999) Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients. J Thorac Cardiovasc Surg 117: 54-63
23. Rusch V et al. (1994) A phase II trial of pleurectomy/ decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma. J Clin Oncol 12: 1156-1163
24. Brancatisano RP et al. (1991) Pleurectomy for mesothelioma. Med J Aust 154: 455-457, 460
25. Soysal O et al. (1997) Pleurectomy/decortication for palliation in malignant pleural mesothelioma: Results of surgery. Eur J Cardiothorac Surg 11: 210-213
26. Achatzy R et al. (1989) The diagnosis, therapy and prognosis of diffuse malignant mesothelioma. Eur J Cardiothorac Surg 3: 445-447
27. Ho L et al (2001) Malignant pleural mesothelioma. Cancer Treat Res 105: 327-373
28. Boutin C et al. (1995) Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma: A randomized trial of local radiotherapy. Chest 108: 754-758
29. Bydder S et al. (2004) A randomised trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma. Br J Cancer 91: 9-10
30. Holsti LR et al. (1997) Altered fractionation of hemithorax irradiation for pleural mesothelioma and failure patterns after treatment. Acta Oncol 36: 397-405
31. Mychalczak BR et al. (1989) Results of treatment of malignant pleural mesothelioma with surgery, brachytherapy, and external beam irradiation [abstract] Endocurie Hypertherm Oncol 5: 245-246
32. Rusch VW et al. (2001) A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 122: 788-795
33. Allen AM et al. (2006) Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys 65: 640-645
34. Jang SY et al. (2006) Dosimetric verification for intensity-modulated radiotherapy of thoracic cancers using experimental and Monte Carlo approaches. Int J Radiat Oncol Biol Phys 66: 939-948
35. Berghmans T et al. (2002) Activity of chemotherapy and immunotherapy on malignant mesothelioma: A systematic review of the literature with meta-analysis. Lung Cancer 38: 111-121
36. Robinson BW et al. (2005) Malignant mesothelioma. Lancet 366: 397-408
37. Vogelzang NJ et al. (2003) Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21: 2636-2644
38. Baas P (2002) Chemotherapy for malignant mesothelioma: From doxorubicin to vinorelbine. Semin Oncol 29: 62-69
39. O'Brien ME et al. (2006) A randomised trial in malignant mesothelioma (M) of early (E) versus delayed (D) chemotherapy in symptomatically stable patients: The MED trial. Ann Oncol 17: 270-275
40. Bottomley A et al. (2006) Short-term treatment-related symptoms and quality of life: Results from an international randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: An EORTC Lung-Cancer Group and National Cancer Institute, Canada, Intergroup Study. J. Clin Oncol 24: 1435-1442
41. Weder W et al. (2004) Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. J Clin Oncol 22: 3451-3457
42. Favaretto A (2005) Overview on ongoing or planned clinical trials in Europe. Lung Cancer 49 (Suppl 1): S117-S121
43. Flores RM (2005) Induction chemotherapy, extrapleural pneumonectomy, and radiotherapy in the treatment of malignant pleural mesothelioma: The Memorial Sloan-Kettering experience. Lung Cancer 49 (Suppl 1): S71-S74
44. Krug LM et al. (2005) A multicenter phase 2 trial of neo-adjuvant pemetrexed plus cisplatin (PC) followed by extrapleural pneumonectomy (EPP) and radiation (RT) for malignant pleural mesothelioma (MPM) [abstract]. J Clin Oncol 23 (Suppl): 7179
45. O'Rourke N et al. (2005) A randomised controlled trial of radiotherapy to mesothelioma drain sites [abstract #P-419]. Lung Cancer 49 (Suppl 2): S225-S226